Usana Health Sciences (NYSE:USNA) Altman Z-Score

: 8.86 (As of Today)

View and export this data going back to 1993. Start your Free Trial

Good Sign:

Altman Z-score of 8.84 is strong.

Usana Health Sciences has a Altman Z-Score of 8.86, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Usana Health Sciences's Altman Z-Score or its related term are showing as below:

USNA' s Altman Z-Score Range Over the Past 10 Years
Min: 7.46 Med: 10.71 Max: 15.79
Current: 8.84

During the past 13 years, Usana Health Sciences's highest Altman Z-Score was 15.79. The lowest was 7.46. And the median was 10.71.

Usana Health Sciences Altman Z-Score Historical Data

The historical data trend for Usana Health Sciences's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Usana Health Sciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Altman Z-Score

14.84

10.47

8.89

10.74

7.46

Usana Health Sciences Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Altman Z-Score																9.49	8.44	7.46	8.50	9.12

Competitive Comparison

For the Packaged Foods subindustry, Usana Health Sciences's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annual Data Quarterly Data

Usana Health Sciences Altman Z-Score Distribution

For the Consumer Packaged Goods industry and Consumer Defensive sector, Usana Health Sciences's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Usana Health Sciences's Altman Z-Score falls in comparison to its industry or sector. The grey bar indicates the Altman Z-Score's extreme value range as defined by GuruFocus.

Usana Health Sciences Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Usana Health Sciences's Altman Z-Score for today is calculated with this formula:

1.2

1.4

3.3

0.6

1.0

1.2

0.4543

1.4

0.709

3.3

0.1684

0.6

8.6562

1.0

1.5727

8.86

Trailing Twelve Months (TTM) ended in Jun. 2023:
Total Assets was $602.7 Mil.
Total Current Assets was $387.6 Mil.
Total Current Liabilities was $113.8 Mil.
Retained Earnings was $427.3 Mil.
Pre-Tax Income was 26.81 + 28.501 + 22.802 + 23.224 = $101.3 Mil.
Interest Expense was -0.043 + -0.031 + -0.032 + -0.032 = $-0.1 Mil.
Revenue was 238.202 + 248.36 + 227.96 + 233.3 = $947.8 Mil.
Market Cap (Today) was $1,158.7 Mil.
Total Liabilities was $133.9 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1	=	Working Capital	/	Total Assets
	=	(Total Current Assets - Total Current Liabilities)	/	Total Assets
	=	(387.646 - 113.839)	/	602.68
	=	0.4543

X2	=	Retained Earnings	/	Total Assets
	=	427.311	/	602.68
	=	0.709

X3	=	Earnings Before Interest and Taxes	/	Total Assets
	=	(Pre-Tax Income - Interest Expense)	/	Total Assets
	=	(101.337 - -0.138)	/	602.68
	=	0.1684

X4	=	Market Value Equity	/	Book Value of Total Liabilities
	=	Market Cap	/	Total Liabilities
	=	1158.683	/	133.856
	=	8.6562

X5	=	Revenue	/	Total Assets
	=	947.822	/	602.68
	=	1.5727

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Usana Health Sciences has a Altman Z-Score of 8.86 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Usana Health Sciences (NYSE:USNA) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Be Aware

Altman Z-Score does not apply to financial companies.

Usana Health Sciences Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Usana Health Sciences's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Usana Health Sciences (NYSE:USNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Usana Health Sciences Inc (NYSE:USNA) » Definitions » Altman Z-Score

Comparable Companies

Traded in Other Exchanges

USJ:Germany USJ:Germany

Address

3838 West Parkway Boulevard, Salt Lake City, UT, USA, 84120

Website

http://www.usanahealthsciences.com

Usana Health Sciences Inc is a U.S.-based company that is principally engaged in developing, manufacturing, and selling science-based nutritional and personal-care products. The company operates through direct selling. It owns a number of product lines, such as Essentials, which contains core vitamin and mineral supplements; Optimizers, which includes targeted supplements for individuals' health and nutritional needs; Foods, which consists of low-glycemic meal replacement shakes, snack bars, and other related products; and Sense Beautiful Science, which contains personal-care products related to skin and hair. The company conducts business worldwide, including Asia-Pacific, the Americas, and Europe.

Executives

Xia Ding	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
John Turman Fleming	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84120
Myron W Wentz	director	3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120
Gull Global Ltd	10 percent owner	PO BOX N-4899, 2/F BAHAMAS FINANCIAL CTR, SHIRLEY & CHARLOTTE STREETS, NASSAU C5 BH1-1000
Brent Neidig	officer: CO & Man. Dir. of China	3838 WEST PARKWAY BLVD., WEST VALLEY CITY UT 84120
Peggie Pelosi	director	3838 WEST PARKWAY BLVD., SALT LAKE CITY UT 84111
Joshua Foukas	officer: Chief Legal Officer	3838 WEST PARKWAY BLVD., SALT LAKE CITY X1 84120
J Scott Nixon	director	757 EAST SOUTH TEMPLE, SUITE 150, SALT LAKE CITY UT 84102
David Mulham Mulham	officer: Chief Field Development Office	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Walter Noot	officer: Chief Information Officer	3838 WEST PARKWAY BLVD, SALT LAKE CITY UT 84120
Robert A Sinnott	officer: Chief Scientific Officer	400 55 WATER STREET, VANCOUVER A1 V6B1A1
Feng Peng	director	20 RIDGE ROAD, WARREN NJ 07059
Frederic J Winssinger	director	2944 N 44TH STREET, SUITE 250, PHOENIX AZ 85018
Donald R. Williams	director	3120 BRECKINRIDGE BLVD., DULUTH GA 30099
Rick Stambaugh	officer: Chief Information Officer	3838 W PARKWAY BLVD, SALT LAKE CITY UT 84120